Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.1.3 (
ATPase
)
65,361
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Active transport of conjugated and unconjugated electrophiles out of cells is essential for cellular homeostasis. We have previously identified in human tissues a transporter, DNP-SG [S-(2, 4-dinitrophenyl)glutathione]
ATPase
, capable of carrying out this function [Awasthi et al. (1998) Biochemistry 37, 5231-5238, 5239-5248]. We now report the cloning of DNP-SG ATPase. The sequence of the cDNA clone was identical to that of human
RLIP76
, a known Ral-binding protein.
RLIP76
expressed in E. coli was purified by DNP-SG affinity chromatography. Purified recombinant
RLIP76
: (1) had
ATPase
activity stimulated by DNP-SG or doxorubicin (DOX), and the K(m) values of
RLIP76
for ATP, DOX, and DNP-SG were similar to those reported for DNP-SG ATPase; (2) upon reconstitution with asolectin as well as with defined lipids, catalyzed ATP-dependent transport of DNP-SG and DOX with kinetic parameters similar to those of DNP-SG ATPase; (3) when transfected into K562 cells, resulted in increased resistance to DOX, and increased ATP-dependent transport of DNP-SG and DOX by inside-out membrane vesicles from transfected cells; (4) direct uptake of purified RLIP76 protein into mammalian cells from donor proteoliposomes confers DOX resistance. These results indicate that
RLIP76
, in addition to its role in signal transduction, can catalyze transport of glutathione conjugates and xenobiotics, and may contribute to the multidrug resistance phenomenon.
...
PMID:Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin. 1092 26
We have recently shown that
RLIP76
, a Ral-binding, GTPase-activating protein, is an ATP-dependent transporter of doxorubicin (DOX) as well as glutathione conjugates [Awasthi, S., et al. (2000) Biochemistry 39, 9327-9334].
RLIP76
overexpressed in human cells or transformed E. coli undergoes proteolysis to yield several fragments, including two prominent peptides, N-
RLIP76
(1-367) and C-
RLIP76
(410-655), from the N- and C-terminal domains, respectively. To investigate whether the fragmentation of
RLIP76
has any relevance to its transport function, we have studied the characteristics of these two peptide fragments. Recombinant N-
RLIP76
(1-367) and C-
RLIP76
(410-655) were purified from overexpressing transformed E. coli. While N-
RLIP76
(1-367) readily underwent proteolysis, showing SDS-gel patterns similar to those of
RLIP76
, C-
RLIP76
(410-655) was resistant to such degradation. Both N-
RLIP76
(1-367) and C-
RLIP76
(410-655) had
ATPase
activity (K(m) for ATP, 2.5 and 2.0 mM, respectively) which was stimulated by DNP-SG, DOX, and colchicine (COL). ATP binding to both peptides was confirmed by photoaffinity labeling with 8-azido-ATP that was increased in the presence of compounds that stimulated their
ATPase
activity. Photoaffinity labeling was also increased in the presence of vanadate, indicating trapping of a reaction intermediate in the ATP binding site. The ATP binding sites in N-
RLIP76
(1-367) and C-
RLIP76
(410-655) were identified to be (69)GKKKGK(74) and (418)GGIKDLSK(425), respectively. Mutation of K(74) and K(425) to M residues, in N-
RLIP76
(1-367) and C-
RLIP76
(410-655), respectively, abrogated their
ATPase
activity as well as azido-ATP labeling. Proteoliposomes reconstituted with either N-
RLIP76
(1-367) or C-
RLIP76
(410-655) alone did not catalyze ATP-dependent transport of DOX or COL. However, proteoliposomes reconstituted with a mixture of N-
RLIP76
(1-367) and C-
RLIP76
(410-655) mediated such transport. Proteoliposomes reconstituted with the mixture of mutant peptides lacking
ATPase
activity did not exhibit transport activity. Present studies have identified the ATP binding sites in
RLIP76
, and show that DOX and COL transport can be reconstituted by two fragments of
RLIP76
.
...
PMID:Functional reassembly of ATP-dependent xenobiotic transport by the N- and C-terminal domains of RLIP76 and identification of ATP binding sequences. 1130 Jul 97
We have recently shown that
RLIP76
, a ral-binding GTPase activating protein, mediates ATP-dependent transport of glutathione-conjugates (GS-E) and doxorubicin (DOX) (S. Awasthi et al., Biochemistry 39,9327,2000). Transport function of
RLIP76
was found to be intact despite considerable proteolytic fragmentation in preparations used for those studies, suggesting either that the residual intact
RLIP76
was responsible for transport activity, or that the transport activity could be reconstituted by fragments of
RLIP76
. If the former were true, intact
RLIP76
would have a much higher specific activity for ATP-hydrolysis than the fragmented protein. We have addressed this question by comparing transport properties of recombinant
RLIP76
and human erythrocyte membrane
RLIP76
purified in buffers treated with either 100 or 500 microM serine protease inhibitor, PMSF. The purity and identity of recombinant and human erythrocyte
RLIP76
was established by SDS/PAGE and Western-blot analysis. These studies confirmed the origin of the 38 kDa protein, previously referred to as DNP-SG ATPase, from
RLIP76
. Higher PMSF concentration resulted in lower yield of the 38 kDa band and higher yield of intact
RLIP76
from both human and recombinant source. In contrast, the substrate-stimulated
ATPase
activity in presence of DNP-SG, doxorubicin, daunorubicin, or colchicine were unaffected by increased PMSF; similarly, ATP-dependent transport of doxorubicin in proteoliposomes reconstituted with
RLIP76
was unaffected by higher PMSF. These results indicated that limited proteolysis by serine proteases does not abrogate the transport function of
RLIP76
. Comparison of transport kinetics for daunorubicin between recombinant vs human erythrocyte
RLIP76
revealed higher specific activity of transport for tissue purified
RLIP76
, indicating that additional factors present in tissue purified
RLIP76
can modulate its transport activity.
...
PMID:Purification and functional reconstitution of intact ral-binding Gtpase activating protein, RLIP76, in artificial liposomes. 1173 24
Transport of xenobiotics and their metabolites by ATP-binding cassette (ABC) transporters particularly P-glycoprotein (Pgp) and the multidrug resistance associated protein (MRP1) has been extensively studied during last decade. Our recent studies demonstrate that
RLIP76
, a previously known GTPase-activating protein catalyzes ATP-dependent, uphill transport of anionic glutathione conjugates as well as of weakly cationic anthracyclines including doxorubicin (Adriamycin), a widely used drug in cancer chemotherapy.
RLIP76
has inherent
ATPase
activity, which is stimulated by doxorubicin and glutathione conjugates.
RLIP76
does not meet the criteria for classical ABC proteins such as MRP1 or Pgp, but similar to ABC proteins, it has two ATP-binding sequences, (69)GKKKGK(74) and (418)GGIKDLSK(425). Mutations in these sequences abrogate its ATP-binding,
ATPase
activity, and transport function. Purified
RLIP76
when reconstituted in proteoliposomes mediates ATP-dependent saturable transport of doxorubicin and glutathione conjugates. Transfection of K562 cells with
RLIP76
confers these cells resistance to doxorubicin and 4-hydroxynonenal. Cells enriched with
RLIP76
also acquire resistance to radiation toxicity.
RLIP76
also catalyzes the transport of physiologic ligands such as leukotrienes (LTC4) and the conjugate of 4-hydroxynonenal and glutathione. In some cells (e.g., erythrocytes and lung cancer cells), the majority of transport activity for Adriamycin and glutathione conjugates including LTC4 is accounted for by
RLIP76
. These studies strongly suggest that
RLIP76
-mediated transport of organic ions has physiological and toxicological relevance and that it may play an important role in the mechanism of drug resistance.
...
PMID:RLIP76, a novel transporter catalyzing ATP-dependent efflux of xenobiotics. 1243 96
RLIP76
functions as an ATP-dependent transporter of amphiphilic chemotherapeutic drugs such as doxorubicin (DOX, adriamycin), as well as of glutathione-conjugates of endogenous electrophilic toxins such as 4-hydroxynonenal (4HNE).
RLIP76
couples transport and ATP-hydrolysis with a 1:1 stoichiometry, making the
ATPase
activity of
RLIP76
an excellent surrogate for its transport activity. Present studies were performed to determine the relationship of the
RLIP76
ATPase
activity with DOX and 4HNE resistance in a panel of 13 native human lung cancer cell lines.
RLIP76
was purified from each cell line and homogeneity demonstrated by SDS-PAGE and amino acid composition analysis. Anti-
RLIP76
antibodies were shown by Ouchterlony double immunodiffusion tests to be non-cross-reactive with any other proteins including P-glycoprotein (Pgp) or multidrug resistance associated protein (MRP). These antibodies completely immunoprecipitated
ATPase
activity of purified
RLIP76
fractions, further confirming homogeneity of purified
RLIP76
.
RLIP76
ATPase
purified from NSCLC cell lines was about 2-fold more active than that from SCLC in the absence of the stimulator dinitrophenyl S-glutathione (206+/-47, n=7 vs. 94+/-22, n=6, nmol/min/mg protein, respectively), or in its presence (340+/-60, n=7 vs. 186+/-32, n=6, nmol/min/mg; p<0.01). Partial tryptic digest revealed a 44 kDa internal fragment of
RLIP76
beginning at Thr-294 in NSCLC cell lines. This fragment was absent from all SCLC, suggesting the possibility that the activity of
RLIP76
in SCLC and NSCLC is differentially regulated through post-translational modifications. Taken together, these findings suggest that
RLIP76
activity is a general determinant of 4HNE and DOX resistance, and that its activity contributes to the drug-resistant phenotype of NSCLC.
...
PMID:Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells. 1252 36
We have recently demonstrated that a previously known Ral-binding GTPase activating protein,
RLIP76
, can also catalyze ATP-dependent transport of various structurally unrelated xeno- and endobiotics irrespective of their net charge (Awasthi et al., 2000, Biochemistry, 39: 9327).
RLIP76
is a non-ATP binding cassette (ABC) protein but it has two ATP-binding sites and shows basal
ATPase
activity which is stimulated in the presence of its transport substrates (allocrites) such as doxorubicin (DOX) and S-(2,4-dinitrophenyl) glutathione (DNP-SG). Proteoliposomes reconstituted with purified
RLIP76
catalyze ATP-dependent, saturable transport of DOX, as well as of glutathione-conjugates including leukotrienes (LTC4) and the GSH-conjugate of 4-hydroxynonenal (GS-HNE). In erythrocytes the majority of transport activity for DOX, GS-HNE, and LTC4 is accounted for by
RLIP76
. Cells exposed to mild oxidative stress show a rapid and transient induction of
RLIP76
resulting in an increased efflux of GS-HNE and acquire resistance to oxidative stress mediated toxicity and apoptosis. Cells transfected with
RLIP76
acquire resistance to DOX through increased efflux of the drug suggesting its possible role in the mechanisms of drug-resistance. In this article, we discuss the significance of transport functions of
RLIP76
highlighting its role in the defense mechanisms against oxidative injury, and modulation of signaling mechanisms.
...
PMID:Transport functions and physiological significance of 76 kDa Ral-binding GTPase activating protein (RLIP76). 1254 92
ATP-dependent transport of doxorubicin (DOX) by recombinant human
RLIP76
has been demonstrated previously in reconstituted proteoliposomes. In the preceding communication, we demonstrated that the
ATPase
activity of
RLIP76
was 2-fold higher in NSCLC as compared with SCLC, and it correlated with their inherent DOX resistance. Present studies were performed to determine whether greater
ATPase
activity of
RLIP76
in NSCLC translated into greater
RLIP76
mediated DOX transport, and to determine the overall contribution of
RLIP76
toward total DOX transport. Consistent with the greater
RLIP76
ATPase
activity in NSCLC, DOX transport in artificial proteoliposomes reconstituted with purified
RLIP76
from NSCLC was 1.8-fold greater than in SCLC. Anti-
RLIP76
antibodies completely abrogated DOX transport in these
RLIP76
proteoliposomes, whereas anti-MRP or anti-Pgp antibodies had no effect on transport. DOX transport studies in crude membrane vesicles from SCLC and NSCLC also showed a 2.1-fold higher rate of transport in NSCLC as compared with SCLC. Anti-
RLIP76
IgG, which recognized only
RLIP76
in crude extracts of both SCLC and NSCLC, inhibited 67+/-4% (n=12 cell lines) of total DOX transport in crude membrane vesicles from both SCLC and NSCLC. Inhibition of DOX transport by anti-MRP and anti-Pgp antibody was 35+/-7% (n=12) and 2+/-0.3% (n=12), respectively. The mixture of the three antibodies inhibited DOX transport by 95+/-3% (n=12). These studies demonstrate that DOX transport activity of
RLIP76
is significantly greater in NSCLC as compared with SCLC, and that
RLIP76
is the major DOX transporter in lung cancer cell lines.
...
PMID:Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76. 1263 60
Our studies have shown that
RLIP76
(RALBP1), a 76 kDa Ral-binding, Rho/Rac-GAP and Ral effector protein, is a novel multispecific transporter of xenobiotics as well as GS-Es. Like previously characterized ABC transporters, it mediates ATP-dependent transport of structurally unrelated amphiphilic xenobiotics and displays inherent
ATPase
activity, which is stimulated by its substrate allocrites. It does not have significant sequence homology with ABC transporters and differs from the ABC transporters in several other important aspects, including (i) lack of any close homologs in humans, (ii) lack of a classical Walker domain, (iii) integral membrane association without clearly defined transmembrane domains and (iv) its role as a direct link to Ras/Ral/Rho and EGF-R signaling through its multifunctional nature, including GAP activity, regulation of exocytosis as well as clathrin-coated pit-mediated receptor endocytosis. Its multifunctional nature derives from the presence of multiple motifs, including a Rho/Rac GAP domain, a Ral effector domain binding motif, 2 distinct ATP-binding domains, a H(+)-
ATPase
domain, PKC and tyrosine kinase phosphorylation sites and the ability to undergo fragmentation into multiple smaller peptides which participate as components of macromolecular functional complexes. One of the physiologic functions of
RLIP76
is regulation of intracellular concentration of the electrophilic intermediates of oxidative lipid metabolism by mediating efflux of GS-E formed from oxidative degradation of arachidonic acid, including leukotrienes and the 4HNE-GSH conjugate.
RLIP76
-mediated transport of amphiphilic chemotherapeutic agents such as anthracyclines and vinca alkaloids as well as GS-E produced during oxidative metabolism places this multifunctional protein in a central role as a resistance mechanism for preventing apoptosis caused by chemotherapeutic agents and a variety of external/internal stressors, including oxidative stress, heat shock and radiation.
...
PMID:Transport of glutathione conjugates and chemotherapeutic drugs by RLIP76 (RALBP1): a novel link between G-protein and tyrosine kinase signaling and drug resistance. 1286 21
Increased active transport of LTC(4) observed frequently in multidrug-resistant cancer cells have been attributed to ABC-transporter proteins particularly, MRP1. We have demonstrated recently that a novel non-ABC transporter,
RLIP76
(RALBP1) can also mediate ATP-dependent transport of GSH-conjugates (GS-E) as well as doxorubicin (DOX). We demonstrate
RLIP76
reconstituted in artificial liposomes can catalyze ATP-dependent transport of LTC(4), which can be modulated by PKC-alpha. The
ATPase
activity of E. coli expressed homogenous
RLIP76
was stimulated in a saturable fashion by LTC(4) with half maximal stimulation at 130 nM. Proteoliposomes reconstituted with
RLIP76
catalyzed temperature and osmolar sensitive ATP-dependent transport of LTC(4) with K(m) values of 5.1 mM and 210 nM for ATP and LTC(4), respectively. V(max) for transport was found to be 3.2 nmol/min/mg. Colchicine inhibited LTC(4) transport to 50% at 5.8 microM. PKC-alpha catalyzed phosphorylation of
RLIP76
and increased its transport activity by 2-3-fold. Membrane vesicles prepared from the small (SCLC) and non-small (NSCLC) lung cancer cell lines as well as HL-60 (leukemia) and U937 (lymphoma) cell lines exhibited ATP-dependent transport of LTC(4), which was inhibited by anti-
RLIP76
antibodies. The rate of transport of LTC(4) in SCLC (H69, H378) was half of that observed in NSCLC cell lines but after transfection with
RLIP76
, the transport rate of LTC(4) in H69 became comparable to that in NSCLC cell lines. Anti-
RLIP76
antibodies inhibited LTC(4) transport by 67-81% in all 8 cell lines examined, whereas N-19 anti-MRP1 antibodies inhibited transport of LTC(4) by only 11-26%. These results suggest that
RLIP76
is the major LTC(4) transporter in cancer cells and that its transport activity is regulated by PKC-alpha-mediated phosphorylation.
...
PMID:RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance. 1538 49
RLIP76
, a stress-responsive, multi-functional protein with multi-specific transport activity towards glutathione-conjugates (GS-E) and chemotherapeutic agents is frequently overexpressed in malignant cells. Our recent studies suggest that it plays a prominent anti-apoptotic role selectively in cancer cells. The present studies were performed to compare
RLIP76
activity towards glutathione-conjugates in recombinant and K562 human erythroleukemia cells. The purity and identity of recombinant and K562
RLIP76
was established by SDS-PAGE and Western blot analysis. These studies confirmed the origin of the 38 kDa protein, previously referred to as DNP-SG ATPase, from
RLIP76
. Comparison of
ATPase
activity and transport kinetics for DNP-SG and GS-HNE between recombinant vs. K562
RLIP76
revealed higher specific activity of
ATPase
and transport for recombinant purified
RLIP76
, indicating that additional factors present in recombinant purified
RLIP76
can modulate its transport activity.
...
PMID:Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugates. 1908 90
1
2
Next >>